

Neuland Pharma Research Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 13 Year, 10 Days
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 261.90 Cr
- Revenue Growth 23.87%
- Profit Growth 169.49%
- Ebitda 220.62%
- Net Worth 62.63%
- Total Assets 29.45%
About Neuland Pharma Research
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100TG2012PTC080474
- Company No.
080474
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2012
- Date of AGM
28 Dec 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Neuland Pharma Research Private Limited offer?
Neuland Pharma Research Private Limited offers a wide range of products and services, including Project Management, IT Infrastructure Solution, Business Consultant, Facility Management Services, Web Development & Marketing Services, Website Development Services, Content Writing Service, Research Development Services, Legal Drafting & Litigation Services, Dispute Resolution Service.
Who are the key members and board of directors at Neuland Pharma Research?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Saharsh Davuluri ![]() | Director | 23-Apr-2012 | Current |
Sucheth Davuluri ![]() | Director | 23-Apr-2012 | Current |
Ramamohan Rao ![]() | Director | 23-Apr-2012 | Current |
Financial Performance of Neuland Pharma Research.
Neuland Pharma Research Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 23.87% increase. The company also saw a substantial improvement in profitability, with a 169.49% increase in profit. The company's net worth Soared by an impressive increase of 62.63%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Neuland Pharma Research?
In 2017, Neuland Pharma Research had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Neuland Laboratories Ltd.
Sucheth Davuluri, Saharsh Davuluri and 1 more are mutual person
- Ypo South Asia Chapter
Sucheth Davuluri is a mutual person
- Asvi Therapeutics Private Limited
Sucheth Davuluri, Saharsh Davuluri and 1 more are mutual person
- Pattancheru Enviro-Tech Limited
Ramamohan Rao is a mutual person
Charges (Loans)
₹0
₹261.90 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 150.90 Cr
- Export-Import Bank Of India : 76.00 Cr
- Bank Of India : 20.00 Cr
- Sbi Global Factors Limited : 15.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Jun 2014 | Bank Of India | ₹20.00 Cr | Satisfied |
08 Aug 2013 | Export-Import Bank Of India | ₹10.00 Cr | Satisfied |
08 Aug 2013 | Export-Import Bank Of India | ₹36.00 Cr | Satisfied |
08 Aug 2013 | Export-Import Bank Of India | ₹30.00 Cr | Satisfied |
08 Aug 2013 | Sbi Global Factors Limited | ₹15.00 Cr | Satisfied |
How Many Employees Work at Neuland Pharma Research?
Unlock and access historical data on people associated with Neuland Pharma Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Neuland Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuland Pharma Research's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Neuland Pharma Research
Recent activity within the organization
- Annual General Meeting
Neuland Pharma Research Private Limited last Annual general meeting of members was held on 28 Dec 2017 as per latest MCA records.
- Charges
A charge registered on 27 Jun 2014 via Charge ID 10507554 with Bank Of India was fully satisfied on 07 Aug 2017.
- Balance Sheet
Neuland Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad.
- Charges
A charge registered on 08 Aug 2013 via Charge ID 10445664 with Export-Import Bank Of India was fully satisfied on 02 Mar 2017.
- Charges
A charge registered on 08 Aug 2013 via Charge ID 10446304 with Sbi Global Factors Limited was fully satisfied on 27 Oct 2016.
- Charges
A charge registered on 08 Aug 2013 via Charge ID 10445670 with Export-Import Bank Of India was fully satisfied on 19 Apr 2016.
Recent News, Updates & Announcement
- Mumbai Companies Raise Over Rs837 Crore Through QIP Offerings, Showing Strong Investor Confidence.
Mumbai companies Minda Corp., Neuland Laboratories, and Simplex Infrastructure raised Rs837.79 crore through QIP offerings. Minda Corp. sold shares at Rs173.47 per share, showing investors' confidence in their business. Neuland Laboratories and Simplex Infrastructure also successfully raised funds through QIP. QIP is a way for listed companies to sell equity shares to qualified institutional buyers. In 2018, 17 companies have raised Rs11,049.8 crore through QIPs. In 2017, 43 companies raised Rs56,152 crore, the highest since 2009..
Frequently asked questions
What is the Incorporation or founding date of Neuland Pharma Research Private Limited?
Neuland Pharma Research Private Limited was incorporated on 23 Apr 2012.
What is authorized share capital and paid-up capital of Neuland Pharma Research Private Limited?
The authorized share capital of Neuland Pharma Research Private Limited is ₹ 9.50 Cr and paid-up capital is ₹ 5.00 Cr.
Who are the current board members & directors of Neuland Pharma Research Private Limited?
Currently 3 directors are associated with Neuland Pharma Research Private Limited.
- Sucheth Rao Davuluri
- Saharsh Rao Davuluri
- Ramamohan Davuluri Rao
What is the registered address of Neuland Pharma Research Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Neuland Pharma Research Private Limited is Sanali Info Park 'A' Block Ground Floor 8-2-120/113 Road No. 2 Banjara Hills, India, Hyderabad, Telangana, 500034.
What is the corporate identification number (CIN) and company number of Neuland Pharma Research Private Limited?
The corporate identification number (CIN) of Neuland Pharma Research Private Limited is U73100TG2012PTC080474 and the company number is 080474 as per Ministry of Corporate Affairs (MCA).
What is the official website of Neuland Pharma Research Private Limited?
The Official website of Neuland Pharma Research Private Limited is https://www.neulandlabs.com
What has been the recent revenue trend for Neuland Pharma Research Private Limited?
According to the financial reports for the fiscal year 2017, the revenue trend for Neuland Pharma Research Private Limited has risen by 23.87%.
What change has been observed in the net worth of Neuland Pharma Research Private Limited, and by what percentage?
The financial reports for the fiscal year 2017 indicates that The net worth of Neuland Pharma Research Private Limited has experienced an upsurge of 62.63%.
When was the last Balance Sheet of Neuland Pharma Research Private Limited filed with the ROC?
The most recent Balance Sheet for Neuland Pharma Research Private Limited was filed with the ROC on 31 Mar 2017.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
VC
Viswanath ChibroluAlternate DirectorTD
Tirunelveli DevarajanDirector
Similar Companies Based on Accounting and Financial Analysis
- Price Waterhouse Chartered Accountants L Lp Central Delhi, Delhi, India
- Mahindra Integrated Business Solutions Private Limited Mumbai, Maharashtra, India
- Kpmg Global Delivery Center Private Limited Bangaluru, Karnataka, India
- Deloitte Touche Tohmatsu India Llp Mumbai, Maharashtra, India
- Deloitte Haskins & Sells Llp Mumbai, Maharashtra, India
- Asc Consulting Private Limited Delhi, India
- Accelya Solutions India Limited Pune, Maharashtra, India
- American Express(India) Private Limited Delhi, India